Insulin Pump Market Revenue to Attain USD 13.43 Bn by 2033


19 Sep 2025

Share : linkedin twitter facebook

The global insulin pump market revenue reached USD 7.12 billion in 2025 and is predicted to attain around USD 13.43 billion by 2033 with a CAGR of 8.25%.

Insulin Pump Market Revenue Statistics

An insulin pump is a device that delivers insulin via a small plastic tube. It is small in size. It pumps insulin continuously day and night. The machine can produce insulin more rapidly before meals. It can help some people with diabetes in managing blood glucose. It is a battery-operated device. It can be worn on a belt or put in a pocket. The plastic tube is inserted just under the skin. People use it to release extra insulin doses to handle rises in blood sugar levels. It helps people manage their blood sugar. It delivers insulin at specific times.

It is a more flexible option than insulin pen injections. It doesn't have to be permanent. It is about the size of a small cell phone and is a small, computerized device. Insulin regulates our blood sugar. People who have diabetes use insulin injections to handle their blood sugar. It is a good option for people with Type 1 diabetes. It delivers a steady supply of insulin, even for kids and others.  

Growth Factors 

Rapid technological advancements majorly drive the global market. In line with this, the increasing adoption of insulin pumps significantly contributes to global market growth. Furthermore, these pumps are widely used over traditional methods. These are convenient for people who need more than one insulin injection daily. It is less invasive and hence has rising demand. The increasing geriatric population and rising number of people who have diabetes significantly contribute to the market growth across the globe. 

The growing prevalence of obesity positively influences the market growth. The companies are developing advanced insulin pumps with sophisticated technology. Home infusion therapy and artificial pancreas offer numerous opportunities for market growth. The rising awareness regarding the benefits of insulin pumps creates a positive outlook for the market. An increase in the incidence of diabetes catalyzes market growth. Factors such as obesity and unhealthy lifestyles propel product demand. 

Obesity is the main reason behind diabetes. The growing incidence of type 2 diabetes favors market growth. High cholesterol and smoking also lead to diabetes. Diabetes leads to the inability of the pancreas to produce insulin. It then leads to lower glucose levels in the body. The changing lifestyles significantly contribute to market growth. The consumption of alcohol and smoking leads to diabetes. The rising need for continuous monitoring of blood sugar levels positively influences the market growth. With the increase in awareness regarding diabetes, the demand for the product is rising. Insulin pumps are safe, convenient, and provide accurate results. 

The factors above are expected to contribute to the market growth across the globe significantly. The growing initiatives by governments across the countries to raise awareness about diabetes create a positive outlook for the market.  

Insulin Pump Market Report Coverage

Report Attribute Key Statistics
Market Revenue in 2025 USD 7.12 Billion
Market Revenue by 2033 USD 13.43 Billion
CAGR from 2025 to 2033 8.25%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2024
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Segment Insights

Based on type, the tethered pumps dominated the market and accounted for the largest revenue share. These pumps have tubing between the pump and the cannula. This is due to its reliability and flexibility. The patch pump is expected to witness a promising CAGR in the coming years. These pumps are small and can be attached to the skin's surface. It offers various benefits which lead to its high demand. It is remote control and is integrated with calculators and helps in lowering the overdosage of insulin and other effects associated with it.  

Based on the product, Medtronic's MiniMed insulin pumps dominated the market and captured the largest revenue share. Rapid advancements in technology contribute significantly to market growth. The strong foothold of Medtronic creates a positive outlook for the market. The tandem pump is expected to witness a promising CAGR in the coming years. The product is seeing increasing demand due to its small size, compact size, and capacity to hold approximately 300 units of insulin pumps. It is user-friendly and convenient for patient use. 

Based on accessories, insulin set insertion devices dominated the market and accounted for the largest revenue share. This is due to its increasing usage in general infusion. The insulin reservoir or cartridges is expected to witness a promising CAGR in the coming years. This is due to the rising demand for tethered pumps.  

Based on end-use, hospitals and clinics dominated the market and accounted for the largest revenue share. This is due to the widespread availability of skilled healthcare professionals. Heavy government funding and rising private sector investment create a positive market outlook. Homecare is expected to witness a promising CAGR in the coming years. This is due to increasing awareness about the product and its rising demand for use at home.  

Regional Insights

North America

United States Insulin Pump Market Trends

The United States is a key contributor to the insulin pump market. The increasing prevalence of Type 1 & Type 2 diabetes in the country increases demand for insulin pumps. The well-established healthcare systems and focus on diabetes management increase the adoption of insulin pumps. The strong insurance coverage plans like private insurance & Medicare fuel the adoption of insulin pumps. The increasing awareness about diabetes and growing technological advancements, like hypoglycemic episodes and glycemic control, increases the adoption of insulin pumps. The presence of key manufacturers like Insulet Corporation, Medtronic, and Tandem Diabetes Care drives the market growth.

Asia Pacific

China Insulin Pump Market Trends

China is a major contributor to the insulin pump market. The strong presence of a large diabetic population increases demand for insulin pumps. The rising awareness about diabetes management among younger people increases the adoption of insulin pump. The strong government support for digital health and healthcare infrastructure increases demand for insulin pumps. The increasing integration of insulin pumps in healthcare systems and national health insurance plans supports the overall growth of the market.

India Insulin Pump Market Trends

India is significantly growing in the insulin pump market. The increasing prevalence of type 2 diabetes and the presence of a large pre-diabetic population increase demand for insulin pumps. The growing awareness about healthcare professionals and the public increases the adoption of insulin pumps. The growing advancements in insulin pump technology, like continuous glucose monitoring and hybrid closed-loop systems, help the market growth. The strong government support for advanced diabetes management technologies and focus on better management of chronic disease increases adoption of insulin pumps, driving the overall growth of the market.

Europe

Europe is growing at a notable rate in the insulin pump market. The growing prevalence of type 1 diabetes and focus on advanced diabetes management increases demand for insulin pumps. The strong government support for diabetes care and increasing focus on personalised care increases demand for insulin pumps. The well-developed reimbursement policies and growing technological advancements, like integration with smart features, increase the adoption of insulin pumps, supporting the overall market growth. 

Market Dynamics

Market Driver: Increasing Prevalence of Diabetes 

The Increasing Prevalence of diabetes significantly contributes to market growth. In line with this, the rising prevalence of type 1 diabetes positively influences the global market growth. Furthermore, developing advanced pumps integrated with advanced technologies, such as Artificial Intelligence (AI) and Machine Learning (ML), creates a positive outlook for the market. Apart from this, the rising geriatric population catalyzes market growth. Moreover, the benefits offered by these devices, such as improved monitoring of blood sugar levels, continuous flow of insulin, and rapid adoption, propel market growth. Besides, market players are launching technologically advanced products to maintain a competitive edge. 

Market Opportunity: Recent Product Approvals, along with the Presence of a Robust Pipeline 

The recent approval of products and the presence of a robust pipeline offer numerous opportunities for market growth. In line with this, increasing demand for these products among people with diabetes significantly contributes to market growth. Furthermore, the market players are investing in research and development activities for technologically advanced products. The launch of new products in the market positively influences market growth. The rising insulin-dependent population catalyzes market growth and offers lucrative opportunities to the market players. Smart technologies, such as AI, are rapidly integrated. The development of AI-enabled insulin pumps is expected to favor market growth.  

Market Restraint: High costs 

The high costs of insulin pumps restrict market growth. The rising prevalence of type 1 and 2 diabetes significantly contributes to the product demand. However, the high cost of these pumps is expected to hamper the market growth. The cost also involves additional costs. The costs could also differ. The high price is restricting the adoption of insulin pumps across the globe.  

Market Challenges: Lack of awarenes

The lack of awareness about the treatment options for diabetes challenges market growth, especially in developing countries. The inadequate reimbursement policies in developing countries limit insulin pumps' adoption across the globe. The rising expenditure associated with insulin pumps impedes market growth. The limited reimbursement challenges product adoption across developing countries.  

Recent Developments: 

  • In June 2022, Insulet Corporation invested USD 200 million in its upcoming manufacturing facility in Johor. This would boost its worldwide manufacturing capabilities. 
  • In April 2022, Ypsomed collaborated with Abbott and CamDiab to develop an integrated AID. It is developed to connect Abbott's FreeStyle Libre 3 with Ypsomed's MyLife YpsoPump. 
  • In June 2022, Diabeloop and SOOIL Development Company entered into a partnership for worldwide development at the American Diabetes Association Scientific Sessions. 

Market Key Players:

  • Medtronic Plc
  • Insulet Corporation
  • Medzer
  • Microport Scientific
  • Eoflow
  • Debiotech S.A.
  • Lenomed Medical
  • Microtech Medical
  • Cequr SA
  • F. Hoffmann La Roche AG
  • Ypsomed AG
  • Zealand Pharma
  • Terumo Corporation
  • Vicentra B.V.

Market Segmentation:

By Pump Type

  • Tethered Pump
  • Patch Pump

By Application

  • Battery
  • Insulin Set Insertion Devices
  • Insulin Reservoir

By Disease Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals
  • Clinics
  • Homecare
  • Laboratories

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/1413

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344

 

Related Reports